262.19 0.00 (0.00%)
After hours: 5:10PM EDT
|Bid||261.70 x 800|
|Ask||262.69 x 1100|
|Day's Range||260.06 - 266.83|
|52 Week Range||205.80 - 272.81|
|Beta (3Y Monthly)||0.75|
|PE Ratio (TTM)||20.57|
|Earnings Date||Jan 14, 2019 - Jan 18, 2019|
|Forward Dividend & Yield||3.60 (1.36%)|
|1y Target Est||305.36|
In the latest trading session, UnitedHealth Group (UNH) closed at $262.19, marking a -1.17% move from the previous day.
The latest on developments in financial markets (all times local): 4 p.m. Banks led a broad slide in U.S. stocks on Wall Street, giving the S&P 500 index its fourth straight loss. Bank of America and Citigroup ...
Stock of The Day: Cigna battled doubters for months over its $67 billion Express Scripts takeover. Now, as the deal is almost done, Cigna stock is near a buy point.
As the Dow Jones Industrial Average (DJIA) index experiences a period of heightened volatility, healthcare stocks have proved relatively immune to the wider market swings. Healthcare players Pfizer Inc. ( PFE), UnitedHealth Group Inc. ( UNH) and Merck & Co., Inc. ( MRK), all members of the blue chip index, remain within short reach of their 52-week highs, while the DJIA has fallen 5.8% from its own as of Friday afternoon.
Jim Cramer told his Mad Money viewers on Thursday that the answer to that question is: more fear. Too many investors, he said, feel that more interest rate hikes are already baked into stock prices. It's those investors that need to get scared and throw in the towel before we'll see a real bottom.
How these healthcare giants beat industry watchers' estimates last quarter and their plans for the future.
CNBC's Jim Cramer recommends four stocks for investors to start buying as the market's October volatility continues. Shares of United Continental, Citigroup, UnitedHealth Group and PepsiCo are all ripe for the picking, he says. "In a sell-off during earnings season, you can't have a lot of guesswork.
Stock futures. It's still a stock market correction, so stay in cash. Apple, AMD, UnitedHealth, TJX are among the few top stocks holding up. Breakouts aren't happening.
In a wild week for the Dow , one corner of the index has proven immune to the worst of the volatility: health care. Dow stocks Pfizer PFE , UnitedHealth UNH and Merck MRK remain within reach of 52-week highs, while the Dow hangs 5 percent from its own.
While the broader U.S. stock market has seen more swings than a playground of late, one sector in specific has held up relatively well and defended, thus far, a pattern it has displayed for several months now. Within this sector, shares of U.S. health insurance giant UnitedHealth Group (NYSE:UNH) continue to act well and, following their latest earnings report, look ripe for another break higher. The highest probability and most steadily successful stock market strategy that I have found over my thus far 21-year career as a trader and investor is that of sector and group rotation.
has made an impressive rise over the years, but since April a bearish divergence has been building and a downward correction is overdue. Let's review the charts and indicators of this health care leader. In this daily bar chart of UNH, below, we can see a mixed state of affairs.
According to the Federal Reserve, U.S. industrial production went up by 0.3 percent in September compared to Wall Street expectation of 0.1 percent increase. The stock ended the day 5.05% higher at $146.46.
SINGAPORE (AP) — Asian markets rose on Wednesday as robust U.S. corporate earnings and encouraging data assuaged worries about softening global growth.
UnitedHealth Group Inc. raised its full-year earnings projection for 2018 and offered reassurance about its early outlook for next year, as the company pointed to growth drivers including the continuing expansion of private Medicare plans. UnitedHealth said Tuesday it expects to earn $12.80 a share on an adjusted basis this year, compared with the range of $12.50 to $12.75 a share it previously suggested. UnitedHealth Chief Executive David Wichmann said on a conference call with analysts and investors that for next year, analysts’ consensus projection “captures our 2019 outlook within a typically sized range,” and he said that longer term, the company expects its performance to reflect its goal of 13% to 16% earnings growth.
Another round of strong earnings suggests that health care is living up to its reputation as a defensive industry. UnitedHealth Group and Johnson & Johnson, two industry heavyweights, demonstrated that with third-quarter results on Tuesday by topping analyst expectations on both the top and bottom line and increasing their full year profit guidance. UnitedHealth, the nation’s largest publicly traded health insurer, reported revenue of $56.5 billion and adjusted earnings of $3.41 a share.
Jim Cramer continues his "power rankings" with the health-care sector. His stock picks include a hospital operator, an animal health play and a medical robot maker.